3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
152
Lymphoma, Mantle-Cell
30
Lymphoma, Non-Hodgkin
22
Lymphoma, Follicular
22
Lymphoma
22
Recurrence
21
Neoplasms, Plasma Cell
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myeloid, Acute
12
Waldenstrom Macroglobulinemia
11
Lymphoma, Large B-Cell, Diffuse
11
Immunoglobulin Light-chain Amyloidosis
10
Neoplasms
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, B-Cell
7
Leukemia
6
Carcinoma, Non-Small-Cell Lung
6
Myelodysplastic Syndromes
5
Hematologic Neoplasms
5
Brain Neoplasms
5
Amyloidosis
5
Lymphoma, Large-Cell, Immunoblastic
4
Hematologic Diseases
4
Congenital Abnormalities
4
Prostatic Neoplasms
3
Paraproteinemias
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Erythroblastic, Acute
3
Interventions
antineoplaston AS 2-1
3
antineoplaston A10
3
dactolisib
2
Temozolomide
2
Irinotecan
2
Everolimus
2
Bevacizumab
2
surufatinib
1
spartalizumab
1
poly ICLC
1
plerixafor
1
pasireotide
1
fosbretabulin
1
cixutumumab
1
adavosertib
1
Vaccines
1
TH 302
1
Sunitinib
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation
1
PM 00104
1
Lapatinib
1
Immunologic Techniques
1
Immunoglobulin G
1
Genistein
1
Fentanyl
1
Donepezil
1
Disulfides
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive
×
Bortezomib
×
Clear all
No trials found.